Su Bing-Bing, Zhu Chao-Jie, Cao Jun, Peng Rui, Tu Dao-Yuan, Jiang Guo-Qing, Jin Sheng-Jie, Wang Qian, Zhang Chi, Bai Dou-Sheng
Department of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Department of Hepatobiliary Surgery, The Yangzhou Clinical Medical College of Xuzhou Medical University, Yangzhou, China.
Surg Endosc. 2025 Apr;39(4):2540-2550. doi: 10.1007/s00464-025-11631-6. Epub 2025 Mar 3.
Tumor recurrence post-operation of hepatocellular carcinoma (HCC) impacts patient prognosis. Identifying and predicting 5-year HCC recurrence following surgery remains a substantial challenge.
We included 338 patients diagnosed with HCC who underwent surgery from January 2013 to December 2018. Traditional logistic regression, random forest (RF), and LASSO regression methods were used to develop a predictive model for 5-year recurrence. The findings were presented visually using nomogram. The accuracy and sensitivity of the predictive model were evaluated by receiver operating curves (ROC) and decision curve analysis (DCA).
Of the 338 patients, 172 (50.9%) experienced 5 years recurrence, with a gender distribution of 79.7% males. Univariate and multivariate logistic regression analysis identified that three independent predictors of 5-year HCC recurrence (all P < 0.001). The area under the curve (AUC) value of the model (Model-1) constructed was 0.678. Then we combined LASSO regression and RF construct a predictive model including six factors: age, transarterial chemoembolization (TACE), microvascular invasion (MVI), alcohol, size, and number. The AUC of the model (Model-2) constructed was 0.733. DeLong's test results showed that Model-2 had significantly better prediction ability compared with Model-1 (P = 0.004). DCA also demonstrated that Model-2 had better predictive accuracy (P < 0.05). Then we constructed a nomogram, and Kaplan-Meier analysis showed that patients in the low-risk group had significantly better prognosis than the high (P < 0.001).
The predictive accuracy of our model, incorporating factors, such as age, alcohol, size, number, MVI, and TACE, significantly enhances clinical practice management by accurately forecasting 5 years HCC recurrence.
肝细胞癌(HCC)术后肿瘤复发影响患者预后。识别和预测HCC术后5年复发仍然是一项重大挑战。
我们纳入了2013年1月至2018年12月期间诊断为HCC并接受手术的338例患者。使用传统逻辑回归、随机森林(RF)和LASSO回归方法建立5年复发预测模型。使用列线图直观呈现研究结果。通过受试者工作特征曲线(ROC)和决策曲线分析(DCA)评估预测模型的准确性和敏感性。
338例患者中,172例(50.9%)出现5年复发,男性性别分布占79.7%。单因素和多因素逻辑回归分析确定了HCC 5年复发的三个独立预测因素(均P<0.001)。构建的模型(模型1)的曲线下面积(AUC)值为0.678。然后我们结合LASSO回归和RF构建了一个包含六个因素的预测模型:年龄、经动脉化疗栓塞术(TACE)、微血管侵犯(MVI)、饮酒、肿瘤大小和肿瘤数量。构建的模型(模型2)的AUC为0.733。DeLong检验结果显示,模型2与模型1相比具有显著更好的预测能力(P=0.004)。DCA也表明模型2具有更好的预测准确性(P<0.05)。然后我们构建了列线图,Kaplan-Meier分析显示低风险组患者的预后明显优于高风险组(P<0.001)。
我们的模型纳入年龄、饮酒、肿瘤大小、肿瘤数量、MVI和TACE等因素,通过准确预测HCC 5年复发,显著提高了临床实践管理水平。